In this issue:
Life expectancy and income of patients with sickle cell disease
Rivaroxaban vs. VKA in APS
Biosimilar G-CSF for PBSC mobilisation
Eltrombopag for immune thrombocytopenia secondary to chronic LPDs
Systemic amyloidosis: developments in diagnosis, risk assessment and management
Extended edoxaban treatment in cancer-associated VTE
Thrombosis according to platelet count and haematocrit
Prophylactic and pre-emptive azacitidine for myeloid neoplasms after allogeneic SCT
Please login below to download this issue (PDF)